Clinically, our studies emphasized on the prognostic impact of naïve-like B cells as well as the roles of the genes uniquely expressed by naïve-like B cells, such as TLR10, FCRL1, BLK, and TNFRSF13B in NSCLC. Here, BLK is linked to non-small cell lung carcinoma.